NJ State Employees Deferred Compensation Plan - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,940
+80.1%
30,0000.0%0.00%0.0%
Q2 2023$4,965
-83.0%
30,0000.0%0.00%
-80.0%
Q1 2023$29,280
-6.2%
30,0000.0%0.01%0.0%
Q4 2022$31,200
-10.9%
30,0000.0%0.01%
-16.7%
Q3 2022$35,000
-37.5%
30,0000.0%0.01%
-33.3%
Q2 2022$56,000
-38.5%
30,0000.0%0.01%
-25.0%
Q1 2022$91,000
-19.5%
30,0000.0%0.01%
-14.3%
Q4 2021$113,000
-27.1%
30,0000.0%0.01%
-33.3%
Q3 2021$155,000
+34.8%
30,0000.0%0.02%
+40.0%
Q2 2021$115,000
+49.4%
30,0000.0%0.02%
+36.4%
Q1 2021$77,000
+2.7%
30,0000.0%0.01%
-8.3%
Q4 2020$75,000
+21.0%
30,0000.0%0.01%
+9.1%
Q3 2020$62,000
-33.3%
30,0000.0%0.01%
-35.3%
Q2 2020$93,000
+36.8%
30,0000.0%0.02%
+6.2%
Q1 2020$68,000
-37.6%
30,0000.0%0.02%
-15.8%
Q4 2019$109,000
+6.9%
30,0000.0%0.02%0.0%
Q3 2019$102,00030,0000.02%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 9,775,849$2,913,2031.93%
Aquilo Capital Management, LLC 3,303,190$984,3510.89%
CM Management, LLC 649,400$193,5210.20%
BVF INC/IL 20,609,863$6,141,7390.17%
WEALTH EFFECTS LLC 11,700$3,4870.00%
NJ State Employees Deferred Compensation Plan 30,000$8,9400.00%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 14,000$4,1720.00%
ACADIAN ASSET MANAGEMENT LLC 962,358$2860.00%
TWO SIGMA ADVISERS, LP 24,400$7,2710.00%
Tower View Wealth Management LLC 1,000$00.00%
View complete list of PIERIS PHARMACEUTICALS INC shareholders